Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew L. Sherman currently holds 144,290 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew L. Sherman has been a net seller of DCPH stock. They have purchased $0 and sold $8.7M worth of shares.
Matthew L. Sherman's most recent insider trade was on Jun 11, 2024, when they sold 82,265 shares at $0.00 per share.
Matthew L. Sherman serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 189 insider transactions totaling $8.7M over their tenure at the company.
Matthew L. Sherman holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Matthew L. Sherman has shown a selling trading pattern, with $0 in total purchases and $8.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew L. Sherman was on Sep 12, 2017, when they sold $638.0K worth of XLRN shares. This transaction involved 16,650 shares at $38.32 per share.
Matthew L. Sherman currently owns 144,290 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew L. Sherman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew L. Sherman has 189 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Matthew L. Sherman and 40,000+ other insiders.